Lung Transplant in India – Single & Bilateral
Lung transplant in India from $35,000 — 95% cheaper than the US. Expert thoracic surgeons at JCI-accredited hospitals. Single-lung, bilateral, and heart-lung procedures for international patients.
Estimated cost: $35,000 – $55,000 · Average stay: 21–35 days
A lung transplant replaces one or both diseased lungs with healthy donor lungs, offering a life-saving option for patients with end-stage pulmonary disease who have exhausted all other treatments. India has emerged as a credible global destination for lung transplantation, with specialist centres in Chennai, Hyderabad, and Delhi recording outcomes comparable to leading Western programmes — at roughly 5–8% of US costs.
Conditions routinely treated with lung transplantation in India include idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD), cystic fibrosis, pulmonary arterial hypertension, bronchiectasis, and lymphangioleiomyomatosis. India's transplant teams are internationally trained and work within the legal framework of India's Transplantation of Human Organs and Tissues Act.
Gaf Healthcare supports international patients through listing, pre-transplant evaluation, accommodation arrangements near the transplant centre, and long-term follow-up coordination.
What is a Lung Transplant?
A lung transplant is a major surgical procedure in which irreversibly diseased lungs are replaced with healthy lungs from a deceased donor. Single-lung transplant replaces one lung and is used for fibrotic lung diseases. Bilateral sequential lung transplant (BSLT) replaces both lungs in sequence and is the procedure of choice for COPD, cystic fibrosis, and pulmonary hypertension. Heart-lung transplant — replacing both organs simultaneously — is performed when both the heart and lungs are irreparably damaged.
Organ allocation in India is governed by the Transplant Authority and priority listing based on urgency score. Wait times vary by blood type and lung size compatibility. Living-lobe donation — where two family members donate lower lobes each — is available for selected recipients at some centres.
Who Needs a Lung Transplant?
Lung transplant is indicated for patients with end-stage lung disease — defined as a forced vital capacity (FVC) below 50% predicted, severe exercise limitation, or progressive oxygen dependence — despite optimal medical therapy. Common diagnoses include idiopathic pulmonary fibrosis (IPF), COPD, cystic fibrosis, pulmonary arterial hypertension, bronchiectasis, and re-transplantation for chronic lung allograft dysfunction. Patients must be medically fit for major surgery, committed to lifelong immunosuppression, and free of active malignancy and systemic infections.
How is Lung Transplantation Performed?
Pre-transplant evaluation includes pulmonary function tests, echocardiogram, CT chest, blood typing, cross-match, and multi-organ function assessment. Patients undergo pre-habilitation to optimise fitness before transplant.
The transplant is performed under general anaesthesia with cardiopulmonary bypass or ECMO support. The diseased lung is excised and the donor lung connected via bronchial anastomosis, pulmonary artery anastomosis, and pulmonary vein anastomosis. Bilateral procedures repeat this sequence for both sides. ICU ventilator support follows for 3–14 days before stepdown to the ward. Immunosuppression with tacrolimus, mycophenolate mofetil, and corticosteroids begins immediately. Pulmonary rehabilitation starts as soon as the patient is extubated.
Procedure Steps
- Comprehensive pre-transplant evaluation: PFTs, echocardiogram, CT chest, blood typing, cross-match
- Listing with Transplant Authority of India; donor organ allocation by urgency and compatibility
- Pre-anaesthetic workup; cardiopulmonary bypass or ECMO standby prepared
- Thoracotomy or clamshell incision; diseased lung excised preserving hilar anatomy
- Donor lung implantation: bronchial anastomosis, pulmonary artery, and pulmonary vein connections
- Bilateral procedure: contralateral side implantation on same bypass run
- Weaning from bypass; haemostasis; chest drains; chest closure
- ICU ventilator support 3–14 days; immunosuppression initiation with tacrolimus, mycophenolate, steroids
- Daily bronchoscopy surveillance; physiotherapy-led pulmonary rehabilitation
- Discharge with lifelong immunosuppression and structured outpatient follow-up plan
Cost Comparison Worldwide
Country — Range — Savings
--- — --- — ---
India — $35,000 – $55,000 — Save 94%
UAE — $350,000 – $500,000 — Save 90%
United States — $750,000 – $1,200,000 — —
United Kingdom — $400,000 – $600,000 — —
India offers lung transplantation at roughly 5–8% of US costs — one of the largest healthcare cost differences in the world. Costs include surgery, cardiopulmonary bypass perfusionist fees, ICU stay, initial immunosuppression, and hospital stay of 21–35 days. Long-term immunosuppression maintenance is also substantially cheaper in India than in Western countries.
Recovery & Follow-up
Lung transplant recovery is an extended process. Patients remain in ICU for 3–14 days on ventilator support, followed by 2–3 weeks on the ward for respiratory physiotherapy and rehabilitation. Total hospital stay is 21–35 days for uncomplicated cases. Pulmonary rehabilitation continues as an outpatient for 3–6 months post-discharge. Most patients can fly internationally 6–8 weeks after a smooth transplant. One-year survival is approximately 80–85%.
Recovery Tips
- Follow all immunosuppression schedules without interruption — even a missed dose can trigger rejection.
- Avoid crowded public spaces and known sick contacts for 3–6 months post-transplant.
- Attend all spirometry and bronchoscopy follow-up appointments as scheduled.
- Maintain vaccination schedules as advised — live vaccines are avoided post-transplant.
- Report any new breathlessness, fever, or decline in spirometry values immediately to your transplant team.
Risks & Complications
Lung transplant carries significant short- and long-term risks including primary graft dysfunction in the immediate post-operative period, acute rejection (most common in the first year), chronic lung allograft dysfunction (CLAD) — the leading cause of late mortality — cytomegalovirus infection, bacterial and fungal pneumonia, and side effects of long-term immunosuppression including renal impairment, hypertension, diabetes, and elevated cancer risk. India's transplant teams have intensive post-transplant protocols to detect and manage these complications early.
Why GAF Healthcare
Gaf Healthcare places lung transplant patients at India's specialist transplant centres with experienced thoracic surgery teams, dedicated transplant coordinators, and robust post-transplant programmes. We manage pre-travel evaluation, FRRO registration, family accommodation near the centre, 24/7 patient coordinator access, and discharge documentation for seamless handover to your home respiratory physician.
Frequently Asked Questions
How long is the waitlist for a lung transplant in India?
Wait times vary from a few months to over a year depending on blood type, lung size compatibility, and urgency score. Sicker patients are prioritised. Living-lobe donation from two family members can shorten the wait for eligible patients.
What success rate can I expect for a lung transplant in India?
One-year survival is around 80–85% at India's leading centres, broadly matching international benchmarks. Five-year survival is 50–60%. Careful patient selection, experienced surgical teams, and robust post-transplant monitoring are key.
Will my family member be considered as a living donor?
Living-lobe donation — where two family members each donate a lower lobe — is possible in selected cases. Donors undergo thorough physical and psychological assessment. India's transplant committees follow strict ethical and legal guidelines under the Transplantation of Human Organs Act.
What lifelong commitments are required after a lung transplant?
Immunosuppressive medication every day for life, regular clinic reviews with spirometry and bronchoscopy, avoiding sick contacts, maintaining vaccinations, and long-term pulmonary rehabilitation. Gaf Healthcare coordinates continuity of care between India and your home country.
How does Gaf Healthcare support international patients for a lung transplant?
We coordinate pre-travel evaluation, hospital listing, medical visa assistance, accommodation near the transplant centre, 24/7 patient coordinator access, and discharge summary preparation for your home physician.